Venus Medtech completes acquisition of 100% of Cardiovalve

Venus Medtech (Hangzhou) Inc. concluded its acquisition of 100% equity interest in Cardiovalve Ltd., an Israeli transcatheter mitral and tricuspid valve treatment company, on January 26, 2022.

“Venus Medtech (Hangzhou) Inc. announced its acquisition of 100% equity interest in Cardiovalve Ltd. was concluded on 26th January, 2022.”prnewswire.com

• 1 source
• prnewswire.comVenus Medtech Concludes Acquisition of 100% Equity Interest in CardiovalveVenus Medtech (Hangzhou) Inc.Jan 26, 2022

Summarized from public sources; check the original articles before acting on it.